We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Efficacy of dual FLT3/LSD1 inhibition in primary AML samples.
No takes yet. Share an insight, caveat, or question.
Yashar et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: